Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z

Similar documents
Lupus. Fast facts. What is lupus? What causes lupus? Who gets lupus?

Learning about Lupus. Learning About Lupus. Lupus Society of Illinois

UNDERSTANDING SYSTEMIC LUPUS ERYTHEMATOSUS

Definition Chronic autoimmune disease The body s immune system starts attacking itself Can affect most organs and tissues in the body Brain, lungs, he

Systemic Lupus Erythematosus

9/25/2013 SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

To live with lupus, we need to know about lupus.

Arthritis & Rheumatology Clinics of Kansas PATIENT EDUCATION SYSTEMIC LUPUS ERYTHEMATOSUS

Systemic Lupus Erythematosus Defining Lupus

Living with Lupus: An Insider s Perspective

LUPUS CAN DO EVERYTHING, BUT NOT EVERYTHING IS LUPUS LUPUS 101 SLE SUBSETS AUTOIMMUNE DISEASE 11/4/2013 HOWARD HAUPTMAN, MD IDIOPATHIC DISCOID LUPUS

How Is Lupus Diagnosed?

Living with Lupus. LFA - Georgia Gary E Myerson MD Arthritis and Rheumatology of GA

Benlysta (belimumab) Prior Authorization Criteria Program Summary

ONE of the following:

High Impact Rheumatology

Polymyalgia rheumatica and giant cell arteritis

Certain genes passed on from parent to child increase the risk of developing Crohn's disease, if the right trigger occurs.

Corporate Medical Policy

.,Dr Ali Alkazzaz Babylon collage of medicine 2016

The Diagnosis of Lupus

LUPUS. and Medication LUPUSUK 2015

The exact cause of sarcoidosis is unknown. However, gender, race, and genetics can increase the risk of developing the condition:

Lupus. and the Kidneys

10/25/2018. Autoimmunity and how to treat it. Disclosure. Why do we get autoimmunity? James Verbsky MD/PhD Pediatric Rheumatology/Immunology

LUPUS (SLE) MEDICAL SOURCE STATEMENT

Media Guide: Lupus Facts

Conflict of Interest. Systemic Lupus Erythematosus and the Antiphospholipid Syndrome Bonnie L. Bermas, MD Brigham and Women s Hospital.

Benlysta. Benlysta (belimumab) Description

Systemic Lupus Erythematosus

CIBMTR Center Number: CIBMTR Recipient ID: RETIRED. Today s Date: Date of HSCT for which this form is being completed: &

Development of SLE among Possible SLE Patients Seen in Consultation: Long-Term Follow-Up. Disclosures. Background. Evidence-Based Medicine.

Benlysta. Benlysta (belimumab) Description

Rheumatology Primer: What Labs and When

For Your Information. This publication is not copyrighted. You may make copies of it and give out as many as you want.

Living With Lupus. October 15 TH, 2016 Georgia Lupus Empowerment Summit WAMBUI MACHUA, MD

Committee Approval Date: May 9, 2014 Next Review Date: May 2015

SLE and the Antiphospholipid Syndrome

Residual Functional Capacity Questionnaire SYSTEMIC LUPUS ERYTHEMATOSUS

Systemic examination

MANAGING THE PATIENT WITH POSITIVE ANA

Rheumatology Review Update in Internal Medicine COPYRIGHT. Robert H. Shmerling, M.D. Beth Israel Deaconess Medical Center.

DRAFT. TW Case Discussion Guide. Key Learning Objectives

Cigna Drug and Biologic Coverage Policy

CENTRAL NERVOUS SYSTEM VASCULITIS

Ask the Expert: Photosensitivity in Cutaneous Lupus

It s time to bring lupus nephritis out of the shadows

Dr. Venkateswari. R. Dr. Janani Sankar s unit Kanchi Kamakoti CHILDS Trust Hospital

MEDICAL NOTES VOLUME 2

WHAT IS ULCERATIVE COLITIS?

Sarcoidosis. Sarcoidosis Care at National Jewish Health. Causes

MEDICATION GUIDE. BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use

AUTOIMMUNE DISORDERS IN THE ACUTE SETTING

* Autoantibody positive (i.e. antinuclear antibody or ANA titre 1:80 or anti-double stranded (ds) DNA antibody 30 IU/mL)

Pre-talk Questions. Infections and Lupus. Pre-talk Questions. Pre-talk Questions. 1) What is the best treatment for a cold?

Understanding Rheumatoid Arthritis

CSTAR CASE STUDIES: BLOCK F Type 3 Hypersensitivity Reaction

What is ulcerative colitis?

TW Case Discussion Guide Key Learning Objectives

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION

Pain or stiffness in joints after periods of inactivity or excessive use

GRANULOMATOSIS WITH POLYANGIITIS

Lupus Related Kidney Diseases. Jason Cobb MD Assistant Professor Renal Division Emory University School of Medicine October 14, 2017

Systemic Lupus Erythematosus (SLE) Epidemiology of SLE (United States)

Lupus and the heart. Lupus Foundation of America

Central Nervous System (CNS) and Lupus: Learn from the Experts. Betty Diamond, M.D. Feinstein Institute for Medical Research

The information you provide us will greatly help us provide the highest quality and most comprehensive care for you.

Lupus and Your Kidneys. Michael P. Madaio, MD Professor of Medicine Chairman of Medicine Medical College of Georgia Augusta, Georgia

GIANT CELL ARTERITIS. Page 1 of 6 Reproduction of this material requires written permission of the Vasculitis Foundation. Copyright 2018.

THE MANY SHADES OF LUPUS Information for Multicultural Communities

TAKAYASU S ARTERITIS. Second-stage symptoms include:

Myositis and Your Lungs

Policy. Section: Medicine Effective Date: January 15, 2015 Subsection: Pathology/Laboratory Original Policy Date: December 5, 2014 Subject:

Editing file. Color code: Important in red Extra in blue. Autoimmune Diseases

Hydroxychloroquine. Drug information Hydroxychloroquine

Rheumatoid Arthritis

Living with Lupus. Helping Your Patient With Systemic Lupus Erythematosus By Hussein M. Halaby, MBBS, ABIM, FRCPC; and John M. Esdaile, MD, MPH, FRCPC

Evidence Based Treatment of SLE with Treatment Algorithm. Dr. Md. Mujibur Rahman Professor of Medicine Shaheed Suhrawardy Medical College

Systemic lupus erythematosus (SLE) ... PRESENTATIONS... Epidemiology of Systemic Lupus Erythematosus. Based on a presentation by Susan Manzi, MD, MPH

MEDICATIONS: THE GOOD, THE BAD, THE UGLY

Please be sure to check with your insurance company to make sure that Dr. Kohli is covered under your plan.

NEOFEN 60 mg suppository

A number of factors point to the likelihood of a person with RA developing RV:

Systemic Lupus Erythematosus

LUPUS. The Skin and Hair LUPUSUK 2015

Athens Rheumatology Clinic, LLC Sana Makhdumi, MD

Lupus The Clinical Perspective

TOFACITINIB PATIENT INFORMATION ON. (Brand name: Xeljanz ) What is tofacitinib? Important things to remember

Rituximab treatment in autoimmune blistering diseases

Autoimmune Disease. Autoimmunity. Epidemiology. ACR Criteria for Diagnosis. Signs and Symptoms. Autoreactivity: Reactivity to self antigens:

NEW PATIENT REGISTRATION FORM

Neuropsychiatric Systemic Lupus Erythematosus (NPSLE) Case presentations and topic discussion The Rheumatology Unit UMMC experience

Cutanous Manifestation of Lupus Erythematosus. Presented By: Dr. Naif S. Al Shahrani Salman Bin Abdaziz university

COMPLEX CUTANEOUS LUPUS CASES PEARLS AND PITFALLS

The only biologic approved to treat SLE: now with multiple delivery options

LUPUS AND LUPUS KIDNEY DISEASE

Arthritis. that affects the joints.

4. Behçet s - Treatment

PUBLIC SUMMARY OF RISK MANAGEMENT PLAN BURANA 40 MG/ML ORAL SUSPENSION DATE: , VERSION 1

Unconsciously gulping air as they talk, especially when they are upset, excited or nervous

Transcription:

Topic Page: Systemic Lupus Erythematosus Summary Article: Lupus (Systemic Lupus Erythematosus) from Harvard Medical School Health Topics A-Z What Is It? Lupus is thought to develop when the immune system mistakenly attacks the body's own tissues. The immune system attacks many different parts of the body, including the joints, skin, kidney, nervous system (brain, spinal cord and nerves), blood, heart, lungs, digestive system and eyes, causing inflammation and tissue damage. Abnormal antibodies develop (called autoantibodies) that can attach themselves to proteins in the body forming abnormal molecules called immune complexes which can trigger additional inflammation and injury when they are deposited in various organs and tissues. The exact cause of lupus remains a mystery, although scientists are investigating many different possibilities and believe several factors may play a role in the development of the disease. Since 90% of lupus patients are women, usually of childbearing age, researchers think hormones may be involved. Lupus tends to run in families, so genetic factors may play a role. There is evidence that the illness may be more common in people of African, Native American, West Indian and Chinese descent. Some researchers think lupus may be triggered by a virus or another type of infection in people who are genetically susceptible to the disease. Lupus is relatively rare, affecting less than one in 2,000 people. The scientific name of the disease is systemic lupus erythematosus, or SLE. Symptoms In some people, lupus causes only mild illness, but in others it leads to potentially deadly complications. Symptoms tend to come and go. Periods of intensified symptoms are called flares and periods when symptoms disappear are called remissions. Flares can be triggered by many different factors, including sun exposure, infection, medication and possibly pregnancy, but often they occur for no apparent reason. Lupus has the potential to affect many different parts of the body, so it can cause a wide range of symptoms including: Malaise (a general sick feeling) and fatigue Fever Loss of appetite Weight loss Muscle and joint pain, with pain and swelling of the joints A butterfly-shaped rash on the cheeks and bridge of the nose, called a malar rash

Skin photosensitivity (a more widespread rash and flu-like symptoms after exposure to sunlight) Hair loss A "discoid" rash, which appears as firm, round red plaques with raised borders Painful ulcers in the mouth, nose and genital areas Other possible symptoms of lupus include: Neurological symptoms (headaches, seizures, trouble thinking or stroke) Psychiatric symptoms, including psychosis, in which hallucinations may occur Heart problems (abnormal heart rhythms, heart failure, inflammation of the heart muscle or lining) Lung symptoms, especially pleurisy, which causes painful breathing Eye redness or loss of vision Pain or swelling in an extremity due to thrombosis (abnormal blood clots) Some people develop a form of lupus that involves only the skin, called cutaneous lupus or discoid lupus erythematosus. Another form of lupus follows exposure to certain drugs (drug-induced lupus) including procainamide and hydralazine. While drug-induced lupus may cause rash, arthritis and fever that appear similar to the systemic form of lupus, it tends to be milder. Women with lupus can have normal pregnancies and deliver healthy babies. However, pregnant women with lupus are at risk for certain complications such as high blood pressure or worsening kidney function. If the lupus is "quiet" prior to becoming pregnant, these risks are reduced. Women with lupus tend to have an increased risk of having small birthweight babies. Babies born to women with lupus may have a rash, low blood counts and heart problems, a condition called "neonatal lupus." Women with lupus who are planning pregnancy should see an obstetrician experienced in such pregnancies and a rheumatologist. This is particularly important so that medications that may be risky for the fetus can be adjusted or stopped and the lupus can be closely monitored. If the lupus is active, a woman may be advised to delay pregnancy. Diagnosis Your doctor will begin by reviewing your symptoms, your medical history and your exposure to factors that can trigger lupus flares. Next, he or she will examine you, looking for skin rashes on your face or on sun-exposed skin, tenderness or swelling of the joints and ulcers inside your mouth or nose. Your doctor will listen to your heart and lungs with a stethoscope, checking for signs of inflammation of the membrane covering the heart (pericarditis) or inflammation of the membranes covering the lungs (pleuritis). If your doctor suspects you have lupus, he or she will order a blood test to look for a type of antibody, called the antinuclear antibody (ANA), that almost all people with lupus have in their blood. However, since the ANA test can be positive in people who do not have lupus, your doctor may order follow-up

blood tests to look for other types of antibodies. Lupus cannot be diagnosed only on the basis of the ANA test. Your doctor may evaluate your condition using the criteria established by the American College of Rheumatology. Your doctor may diagnose lupus even if you don't meet all of these criteria, which were developed for research studies. If you have had 4 of the 17 lupus criteria at some time during your illness, even if fewer than four are active at the time of diagnosis, the diagnosis is more certain and you may be eligible for entry into a research study of lupus. At least one of the positive criteria must be "clinical" (causing symptoms or affecting a particular part of the body) and one must be a laboratory abnormality (such as an abnormal blood test). The diagnosis can be established without meeting 4 criteria if a kidney biopsy shows evidence of lupus kidney disease along with certain antibodies (including antinuclear antibodies or anti-ds-dna) present in the blood).the lupus criteria include the following: Certain types of rashes (called acute or chronic cutaneous lupus) Discoid rash Hair loss Ulcers in the mouth or nose Arthritis Pericarditis, confirmed by physical exam or electrocardiogram (EKG), or pleuritis, confirmed by physical findings or chest X-ray Kidney disorder, confirmed by finding high levels of protein in the urine or other specific urine abnormalities, especially red cells suggesting inflammation in the kidney Neurological disorder, including seizures or psychosis (a serious psychiatric illness) Blood disorder, including evidence of red blood cell destruction (hemolytic anemia), low white blood cells (leukopenia) or low platelets (thrombocytopenia) Immune disorder This is established by the finding of certain antibodies in the blood, which may include a positive ANA, anti-ds-dna test, or anti-smith antibody test, a positive test for syphilis even though you don't have syphilis or a positive antiphospholipid antibody test (an antibody associated with miscarriage or blood clots). Low complement levels (proteins involved in inflammation) Antibodies linked with red blood cell destruction, called a positive Coombs' test Other tests that may be performed to help diagnose lupus include: Erythrocyte sedimentation rate (ESR), a blood test that indicates the presence of inflammation A skin or kidney biopsy (taking a small tissue sample for laboratory examination) Additional blood tests for autoantibodies

Expected Duration Lupus is a long-lasting (chronic) condition, although its activity often varies over time with periods of active disease (flares) and periods in which the illness is relatively inactive or even completely quiet (remission). Prevention Since doctors haven't determined the cause of lupus, there's no way to prevent it. You may be able to prevent flare-ups of the illness by taking medications as prescribed, avoiding exposure to the sun as much as possible and using sunscreen when you are in the sun. Treatment Lupus may be treated with several different types of medication, including: Nonsteroidal anti-inflammatory drugs (NSAIDS), such as ibuprofen (Advil, Motrin and other brand names) or naproxen (Aleve, Naprosyn and others) Antimalarials, such as hydroxychloroquine (Plaquenil), chloroquine (Aralen), or quinacrine. Recent studies suggest that lupus patients treated with antimalarial medications have less active disease and less organ damage over time. Therefore, many experts now recommend antimalarial treatment for all patients with systemic lupus unless they cannot tolerate the medication. Corticosteroids, such as prednisone (Deltasone and others), hydrocortisone, methylprednisolone (Medrol and others), or dexamethasone (Decadron and others) Immunosuppressives, such as azathioprine (Imuran), cyclophosphamide (Cytoxan, Neosar), methotrexate (Rheumatrex, Folex, Methotrexate LPF), or mycophenolate mofetil (CellCept), or belimumab (Benlysta) When To Call a Professional Call your doctor if you have any of the symptoms of lupus, especially if you develop skin symptoms (malar or discoid rash, photosensitivity, ulcers in your mouth or nose), together with fatigue, fever, joint pain, poor appetite and weight loss. Prognosis Most people with lupus have a normal life span. However, life expectancy and quality of life vary widely depending on severity of illness. Cardiovascular disease, including heart attack, is more common among people with lupus. The presence of cardiovascular disease worsens prognosis. The outlook is also worse if the disease has seriously affected the kidneys or brain. Additional Info National Institute of Arthritis and Musculoskeletal and Skin Diseases Information Clearinghouse National Institutes of Health 1 AMS Circle

Bethesda, MD 20892-3675 Phone: 301-495-4484 Toll-Free: 1-877-226-4267 TTY: 301-565-2966 http://www.niams.nih.gov/ Lupus Foundation of America 2000 L St., N.W. Suite 710 Washington, D.C. 20036 Phone: 202-349-1155 Toll-Free: 1-800-558-0121 http://www.lupus.org/ American College of Rheumatology 2200 Lake Boulevard NE Atlanta, GA 30319 Phone: (404) 633-3777 Fax: (404) 633-1870 http://www.rheumatology.org/ Medical content created by the Faculty of the Harvard Medical School. Copyright by Harvard University. Selected illustrations copyright Harvard University, Krames, and the StayWell Company. Content Licensing by Belvoir Media Group. All rights reserved WARNING: The information contained in this Harvard Health Publication may not be considered current medical content and should only be used for research and reference purposes. As new scientific information becomes available, recommended protocols and treatments may undergo changes. Any practice described in this publication should be applied by the reader in accordance with professional standards of care used in regard to the unique circumstances that may apply in each situation and should not be used as a substitute for a medical professional's judgment. Shmerling, Robert H. (HMFP - Rheumatology)

Copyright 2016 Harvard Health Publications

APA Shmerling, R. H. (2017). Lupus (systemic lupus erythematosus). In Harvard Medical School (Ed.), Health reference series: Harvard Medical School health topics A-Z. Boston, MA: Harvard Health Publications. Retrieved from Chicago Shmerling, Robert H. "Lupus (Systemic Lupus Erythematosus)." In Harvard Medical School Health Topics A-Z, edited by Harvard Medical School. Harvard Health Publications, 2017. Harvard Shmerling, R.H. (2017). Lupus (systemic lupus erythematosus). In Harvard Medical School (Ed.), Health reference series: Harvard Medical School health topics A-Z. [Online]. Boston: Harvard Health Publications. Available from: [Accessed 10 July 2018]. MLA Shmerling, Robert H. "Lupus (Systemic Lupus Erythematosus)." Harvard Medical School Health Topics A-Z, edited by Harvard Medical School, Harvard Health Publications, 2017. Credo Reference,. Accessed 10 Jul. 2018.